Provided by Tiger Fintech (Singapore) Pte. Ltd.

PagerDuty, Inc.

15.56
-1.4300-8.42%
Pre-market: 14.75-0.8100-5.21%04:06 EDT
Volume:2.51M
Turnover:39.53M
Market Cap:1.42B
PE:-26.29
High:16.59
Open:16.48
Low:15.37
Close:16.99
Loading ...

MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia

GlobeNewswire
·
07 Jan

Institutional investors have a lot riding on Precision Drilling Corporation (TSE:PD) with 53% ownership

Simply Wall St.
·
07 Jan

NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody

GlobeNewswire
·
06 Jan

NCNO Stock Price Increases 9% in 6 Months: Should You Buy It Now?

Zacks
·
01 Jan

Options Volatility and Implied Earnings Moves Today, December 26, 2024

TIPRANKS
·
26 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
26 Dec 2024

Why RAPT Therapeutics Stock Gained Over 100% On Monday?

Benzinga
·
24 Dec 2024

Gain Therapeutics Initiates Phase 1b Clinical Trial of Lead Candidate GT-02287 in People with GBA1 and Idiopathic Parkinson’s Disease

GlobeNewswire
·
23 Dec 2024

Options Volatility and Implied Earnings Moves This Week, December 23 – December 26, 2024

TIPRANKS
·
23 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
23 Dec 2024

BRIEF-Baxter - Have Now Restarted 8 Of The 10 Manufacturing Lines At North Cove Site - Website

Reuters
·
20 Dec 2024

Alumis Announces Positive Phase 1 Data for CNS Penetrant TYK2 Inhibitor, A-005

GlobeNewswire
·
19 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
19 Dec 2024

PagerDuty Declines 16% YTD: Should You Buy the Stock on the Dip?

Zacks
·
18 Dec 2024

Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)

Business Wire
·
18 Dec 2024

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial

PR Newswire
·
18 Dec 2024

Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics

GlobeNewswire
·
17 Dec 2024

Larimar Therapeutics Announces Positive Initial Data from Ongoing Long-term Open Label Extension Study & Progress Across Nomlabofusp Program for Friedreich’s Ataxia

GlobeNewswire
·
16 Dec 2024

PagerDuty (NYSE:PD investor three-year losses grow to 41% as the stock sheds US$116m this past week

Simply Wall St.
·
13 Dec 2024

JP Morgan downgrades PagerDuty and C3.ai on market dynamics

Investing.com
·
12 Dec 2024